- Home
- NISN vs CARM Comparison
NISN vs CARM Comparison
Compare NISN & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NISN
- CARM
- Stock Information
- Founded
- NISN 2005
- CARM 2016
- Country
- NISN China
- CARM United States
- Employees
- NISN N/A
- CARM N/A
- Industry
- NISN Metal Fabrications
- CARM Biotechnology: Pharmaceutical Preparations
- Sector
- NISN Industrials
- CARM Health Care
- Exchange
- NISN Nasdaq
- CARM Nasdaq
- Market Cap
- NISN 46.0M
- CARM 41.5M
- IPO Year
- NISN 2016
- CARM N/A
- Fundamental
- Price
- NISN $7.98
- CARM $0.94
- Analyst Decision
- NISN
- CARM Strong Buy
- Analyst Count
- NISN 0
- CARM 3
- Target Price
- NISN N/A
- CARM $12.67
- AVG Volume (30 Days)
- NISN 120.8K
- CARM 183.3K
- Earning Date
- NISN 10-15-2024
- CARM 11-07-2024
- Dividend Yield
- NISN N/A
- CARM N/A
- EPS Growth
- NISN 12.54
- CARM N/A
- EPS
- NISN 4.19
- CARM N/A
- Revenue
- NISN $452,263,984.00
- CARM $20,268,000.00
- Revenue This Year
- NISN N/A
- CARM $50.40
- Revenue Next Year
- NISN N/A
- CARM N/A
- P/E Ratio
- NISN $2.05
- CARM N/A
- Revenue Growth
- NISN 86.06
- CARM 41.13
- 52 Week Low
- NISN $2.50
- CARM $0.80
- 52 Week High
- NISN $22.55
- CARM $3.16
- Technical
- Relative Strength Index (RSI)
- NISN 36.75
- CARM 40.39
- Support Level
- NISN $9.55
- CARM $0.96
- Resistance Level
- NISN $11.31
- CARM $1.01
- Average True Range (ATR)
- NISN 1.18
- CARM 0.06
- MACD
- NISN 0.01
- CARM -0.01
- Stochastic Oscillator
- NISN 10.96
- CARM 4.74
About NISN NiSun International Enterprise Development Group Co. Ltd.
NiSun International Enterprise Development Group Co Ltd is a provider of supply chain solutions and integrated financial services. Nisun is dedicated to providing professional supply chain solutions to Chinese and foreign enterprises and financial institutions. Through its subsidiaries, it is engaged in delivering supply chain solutions, and supply chain trading services to its customers across different industries. The company also provides financial solutions to small and mid-sized enterprises within the supply chain ecosystem. Using its fintech platforms, it provides various financing options, including supply chain financing, trade financing, and receivables financing. Geographically, its operations are predominantly focused on markets within the People's Republic of China.
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.